Literature DB >> 6708167

Permeability of the blood-milk barrier to methylene blue in cows and goats.

G Ziv, J E Heavner.   

Abstract

A 2% aqueous solution of methylene blue was administered as a single intravenous (i.v.) bolus injection (10 mg/kg) to six lactating cows and seven lactating goats and a continuous i.v. drip to five lactating goats. The same dose was administered as a 10% solution by intramammary infusion to five lactating goats. Blood and milk samples collected at various times after these treatments were assayed for the drug by a colorimetric method. Methylene blue, a highly charged molecule (pKa less than or equal to 1), passed readily from blood into milk; drug concentrations in milk 4-36 h after the single i.v. bolus injection were higher than those in blood. When examined at constant methylene blue levels in blood, a milk--blood ratio of 5:1 was observed. After intramammary infusion, the drug passed quickly into systemic circulation, peaked at 3 h and was still detectable in blood 12 h after infusion. The drug appeared in the urine within 15 min after intramammary infusion. The rapid movement of the drug across the blood--milk barrier cannot be explained on the basis of its known physicochemical properties or according to the pH--pKa passive diffusion concept.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6708167     DOI: 10.1111/j.1365-2885.1984.tb00879.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  4 in total

Review 1.  Cellular and molecular actions of Methylene Blue in the nervous system.

Authors:  Murat Oz; Dietrich E Lorke; Mohammed Hasan; George A Petroianu
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

2.  Ribonucleosides as minor milk constituents.

Authors:  E Schlimme; K P Raezke; F G Ott
Journal:  Z Ernahrungswiss       Date:  1991-06

3.  Tartary buckwheat flavonoids relieve the tendency of mammary fibrosis induced by HFD during pregnancy and lactation.

Authors:  Xingchi Kan; Juxiong Liu; Xiangyu Cai; Yaping Huang; Ping Xu; Shoupeng Fu; Wenjin Guo; Guiqiu Hu
Journal:  Aging (Albany NY)       Date:  2021-12-10       Impact factor: 5.682

4.  GPR109A alleviate mastitis and enhances the blood milk barrier by activating AMPK/Nrf2 and autophagy.

Authors:  Wenjin Guo; Wen Li; Yingchun Su; Shu Liu; Xingchi Kan; Xin Ran; Yu Cao; Shoupeng Fu; Juxiong Liu
Journal:  Int J Biol Sci       Date:  2021-10-17       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.